Modulation of apoptosis by HIV protease inhibitors

B. N. Phenix, C. Cooper, C. Owen, Andrew David Badley

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Advances in treatment have transformed the Human Immunodeficiency Virus (HIV) infection from a progressive and ultimately fatal disease to one that can be managed effectively by chronic suppressive antiretroviral therapy. The drugs now used to treat HIV infection not only inhibit viral replication but also have effects on cellular metabolism and homeostasis. Of particular interest to cellular immunologists, members of the HIV Protease Inhibitor (PI) class of antiretroviral agents possess intrinsic immunomodulatory and antiapoptotic properties. This review focuses on the development and use of PI together with their impact on HIV disease, immunity, and apoptosis.

Original languageEnglish (US)
Pages (from-to)295-312
Number of pages18
JournalApoptosis
Volume7
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Protease Inhibitors
Viruses
Virus Diseases
Modulation
HIV
Apoptosis
Anti-Retroviral Agents
Metabolism
Immunity
Homeostasis
Pharmaceutical Preparations
Therapeutics

Keywords

  • Apoptosis
  • CD4 T cell
  • HIV
  • Immunity
  • Protease inhibitor

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Cell Biology

Cite this

Modulation of apoptosis by HIV protease inhibitors. / Phenix, B. N.; Cooper, C.; Owen, C.; Badley, Andrew David.

In: Apoptosis, Vol. 7, No. 4, 2002, p. 295-312.

Research output: Contribution to journalArticle

Phenix, B. N. ; Cooper, C. ; Owen, C. ; Badley, Andrew David. / Modulation of apoptosis by HIV protease inhibitors. In: Apoptosis. 2002 ; Vol. 7, No. 4. pp. 295-312.
@article{6cfc29ce35e340738e53f8b5f37cea33,
title = "Modulation of apoptosis by HIV protease inhibitors",
abstract = "Advances in treatment have transformed the Human Immunodeficiency Virus (HIV) infection from a progressive and ultimately fatal disease to one that can be managed effectively by chronic suppressive antiretroviral therapy. The drugs now used to treat HIV infection not only inhibit viral replication but also have effects on cellular metabolism and homeostasis. Of particular interest to cellular immunologists, members of the HIV Protease Inhibitor (PI) class of antiretroviral agents possess intrinsic immunomodulatory and antiapoptotic properties. This review focuses on the development and use of PI together with their impact on HIV disease, immunity, and apoptosis.",
keywords = "Apoptosis, CD4 T cell, HIV, Immunity, Protease inhibitor",
author = "Phenix, {B. N.} and C. Cooper and C. Owen and Badley, {Andrew David}",
year = "2002",
doi = "10.1023/A:1016168411221",
language = "English (US)",
volume = "7",
pages = "295--312",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Modulation of apoptosis by HIV protease inhibitors

AU - Phenix, B. N.

AU - Cooper, C.

AU - Owen, C.

AU - Badley, Andrew David

PY - 2002

Y1 - 2002

N2 - Advances in treatment have transformed the Human Immunodeficiency Virus (HIV) infection from a progressive and ultimately fatal disease to one that can be managed effectively by chronic suppressive antiretroviral therapy. The drugs now used to treat HIV infection not only inhibit viral replication but also have effects on cellular metabolism and homeostasis. Of particular interest to cellular immunologists, members of the HIV Protease Inhibitor (PI) class of antiretroviral agents possess intrinsic immunomodulatory and antiapoptotic properties. This review focuses on the development and use of PI together with their impact on HIV disease, immunity, and apoptosis.

AB - Advances in treatment have transformed the Human Immunodeficiency Virus (HIV) infection from a progressive and ultimately fatal disease to one that can be managed effectively by chronic suppressive antiretroviral therapy. The drugs now used to treat HIV infection not only inhibit viral replication but also have effects on cellular metabolism and homeostasis. Of particular interest to cellular immunologists, members of the HIV Protease Inhibitor (PI) class of antiretroviral agents possess intrinsic immunomodulatory and antiapoptotic properties. This review focuses on the development and use of PI together with their impact on HIV disease, immunity, and apoptosis.

KW - Apoptosis

KW - CD4 T cell

KW - HIV

KW - Immunity

KW - Protease inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0036022394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036022394&partnerID=8YFLogxK

U2 - 10.1023/A:1016168411221

DO - 10.1023/A:1016168411221

M3 - Article

C2 - 12101389

AN - SCOPUS:0036022394

VL - 7

SP - 295

EP - 312

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 4

ER -